Works matching IS 17407745 AND DT 2013 AND VI 10 AND IP 1

Results: 25

Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. S5, doi. 10.1177/1740774512440342

By:

Babiker, Abdel G;
Emery, Sean;
Fätkenheuer, Gerd;
Gordin, Fred M;
Grund, Birgit;
Lundgren, Jens D;
Neaton, James D;
Pett, Sarah L;
Phillips, Andrew;
Touloumi, Giota;
Vjechaj, Michael J

Publication type:

Article

Commentary on ‘Small-sample behavior of novel phase I cancer trial designs’.

Published in:

2013

By:

Cheung, Ying Kuen

Publication type:

Journal Article

Discussion of ‘Small-sample behavior of novel phase I cancer trial designs’ by Assaf P Oron and Peter D Hoff.

Published in:

2013

By:

Carlin, Bradley P;
Zhong, Wei;
Koopmeiners, Joseph S

Publication type:

Journal Article

Cost–utility analysis conducted alongside randomized controlled trials: Are economic end points considered in sample size calculations and does it matter?

Published in:

2013

By:

Hollingworth, William;
McKell-Redwood, Denise;
Hampson, Lisa;
Metcalfe, Chris

Publication type:

Journal Article

Unblinding following trial participation: Qualitative study of participants’ perspectives.

Published in:

2013

By:

Armstrong, Natalie;
Jackson, Clare J;
McNicol, Sarah;
Dixon-Woods, Mary;
Kenyon, Sara;
Tarrant, Carolyn

Publication type:

Journal Article

Clinician-trialist rounds: 14. Ways to advance your career by saying ‘no’ – part 2: When to say ‘no’, and why.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 181, doi. 10.1177/1740774512467238

By:

Oxman, Andrew D;
Sackett, David L

Publication type:

Article

Bayesian adaptive design for device surveillance.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 5, doi. 10.1177/1740774512464725

By:

Murray, Thomas A;
Carlin, Bradley P;
Lystig, Theodore C

Publication type:

Article

Cost–utility analysis conducted alongside randomized controlled trials: Are economic end points considered in sample size calculations and does it matter?

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 43, doi. 10.1177/1740774512465358

By:

Hollingworth, William;
McKell-Redwood, Denise;
Hampson, Lisa;
Metcalfe, Chris

Publication type:

Article

Moving a randomized clinical trial into an observational cohort.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 131, doi. 10.1177/1740774512460345

By:

Goodman, Phyllis J;
Hartline, Jo Ann;
Tangen, Catherine M;
Crowley, John J;
Minasian, Lori M;
Klein, Eric A;
Cook, Elise D;
Darke, Amy K;
Arnold, Kathryn B;
Anderson, Karen;
Yee, Monica;
Meyskens, Frank L;
Baker, Laurence H

Publication type:

Article

Efficiency of using community organisations as catalysts for recruitment to continence promotion trials.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 151, doi. 10.1177/1740774512460144

By:

Agnew, Rona;
van den Heuvel, Eleanor;
Tannenbaum, Cara

Publication type:

Article

2012 Peer Reviewers.

Published in:: Clinical Trials, 2013, v. 10, n. 1, p. 188, doi. 10.1177/1740774513475407
Publication type:: Article

Small-sample behavior of novel phase I designs: Rejoinder.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 88, doi. 10.1177/1740774512470766

By:

Oron, Assaf P;
Hoff, Peter D

Publication type:

Article

Commentary on ‘Small-sample behavior of novel phase I cancer trial designs’.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 86, doi. 10.1177/1740774512470221

By:

Cheung, Ying Kuen

Publication type:

Article

Discussion of ‘Small-sample behavior of novel phase I cancer trial designs’ by Assaf P Oron and Peter D Hoff.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 81, doi. 10.1177/1740774512469313

By:

Carlin, Bradley P;
Zhong, Wei;
Koopmeiners, Joseph S

Publication type:

Article

Small-sample behavior of novel phase I cancer trial designs.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 63, doi. 10.1177/1740774512469311

By:

Oron, Assaf P;
Hoff, Peter D

Publication type:

Article

A systematic review of on-site monitoring methods for health-care randomised controlled trials.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 104, doi. 10.1177/1740774512467405

By:

Macefield, Rhiannon C;
Beswick, Andrew D;
Blazeby, Jane M;
Lane, J Athene

Publication type:

Article

Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 54, doi. 10.1177/1740774512467404

By:

Chen, Maggie H;
Willan, Andrew R

Publication type:

Article

Accrual by groups in trials with discrete-time survival endpoints.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 32, doi. 10.1177/1740774512464831

By:

Jóźwiak, Katarzyna;
Moerbeek, Mirjam

Publication type:

Article

Assessing the usefulness of health data linkage in obtaining adverse event data in a randomised controlled trial of oral and implant naltrexone in the treatment of heroin dependence.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 170, doi. 10.1177/1740774512467237

By:

Kelty, Erin;
Ngo, Hanh;
Hulse, Gary

Publication type:

Article

Using scratch card technology for random allocation concealment in a clinical trial with a crossover design.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 125, doi. 10.1177/1740774512465496

By:

Beksinska, Mags E;
Joanis, Carol;
Smit, Jenni A;
Pienaar, Jacqueline;
Piaggio, Gilda

Publication type:

Article

Meta-analysis of clinical trial safety data in a drug development program: Answers to frequently asked questions.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 20, doi. 10.1177/1740774512465495

By:

Berlin, Jesse A;
Crowe, Brenda J;
Whalen, Edward;
Xia, H Amy;
Koro, Carol E;
Kuebler, Juergen

Publication type:

Article

Conducting the ACTIVE randomized trial in hospice care: Keys to success.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 160, doi. 10.1177/1740774512461858

By:

Kruse, Robin L;
Parker Oliver, Debra;
Wittenberg-Lyles, Elaine;
Demiris, George

Publication type:

Article

Obtaining surrogate consent for a minimal-risk research study in the intensive care unit setting.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 93, doi. 10.1177/1740774512464727

By:

Larkin, Mary E;
Beauharnais, Catherine C;
Magyar, Kendra;
Macey, Laurel;
Grennan, Kerry B;
Boykin, Emily E;
Russell, Steven J

Publication type:

Article

Unblinding following trial participation: Qualitative study of participants’ perspectives.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 97, doi. 10.1177/1740774512464726

By:

Armstrong, Natalie;
Jackson, Clare J;
McNicol, Sarah;
Dixon-Woods, Mary;
Kenyon, Sara;
Tarrant, Carolyn

Publication type:

Article

Usefulness of prestudy assessment of patient willingness to undergo tissue biopsy for correlative studies in a melanoma vaccine trial.

Published in:

Clinical Trials, 2013, v. 10, n. 1, p. 143, doi. 10.1177/1740774512464438

By:

Judge, Joshua M;
Chianese-Bullock, Kimberly A;
Schroen, Anneke T;
Slingluff, Craig L

Publication type:

Article